|
YWHAZ expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.095800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.415800E-01 |
| Normal-vs-Stage2 |
2.966300E-02 |
| Normal-vs-Stage3 |
6.938400E-01 |
| Normal-vs-Stage4 |
9.173200E-01 |
| Stage1-vs-Stage2 |
8.938200E-03 |
| Stage1-vs-Stage3 |
6.457600E-01 |
| Stage1-vs-Stage4 |
8.460200E-01 |
| Stage2-vs-Stage3 |
4.103800E-02 |
| Stage2-vs-Stage4 |
2.475700E-02 |
| Stage3-vs-Stage4 |
6.174800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.283000E-01 |
| Normal-vs-AfricanAmerican |
3.618200E-01 |
| Normal-vs-Asian |
3.954200E-01 |
| Caucasian-vs-AfricanAmerican |
2.843200E-01 |
| Caucasian-vs-Asian |
3.817600E-01 |
| AfricanAmerican-vs-Asian |
1.086960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.628200E-01 |
| Normal-vs-Female |
7.882600E-01 |
| Male-vs-Female |
6.165200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.123600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.392600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.040800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.265800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.866380E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.707500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.878600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.382600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.775600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.227800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.426200E-01 |
| Classical-VS-Follicular |
2.73729999999972E-07 |
| Classical-VS-Other |
1.388050E-01 |
| Classical-VS-Normal |
4.516200E-01 |
| Tall-VS-Follicular |
1.224560E-03 |
| Tall-VS-Other |
1.162950E-01 |
| Tall-VS-Normal |
3.242200E-01 |
| Follicular-VS-Other |
8.248800E-01 |
| Follicular-VS-Normal |
6.303900E-03 |
| Other-VS-Normal |
2.620000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.534400E-02 |
| Normal-vs-N1 |
6.913400E-01 |
| N0-vs-N1 |
1.872580E-01 |
|
|
